caries management by risk assessment: the cambra ... · caries management by risk assessment: the...

21
© Stuart A. Gansky 2006 Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone Co-investigators: Stuart A. Gansky, Chuck Hoover, Marcia Rapozo-Hilo, Kim Tran, Jane A. Weintraub, Joel White, Robert Wilson, Ling Zhan Mentored students: Lawrence Li, Gloria Khoo, Maureen Khoo, Dan Walton Support: US DHHS/NIH/NIDCR R01 DE 12455 In-kind: OMNII Pharmaceuticals, Oral B, Proctor & Gamble

Upload: phamthu

Post on 10-Apr-2019

234 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

Caries management by risk assessment: The CaMBRA randomized clinical trial

Principal Investigator:John D. B. Featherstone

Co-investigators: Stuart A. Gansky, Chuck Hoover, Marcia Rapozo-Hilo,Kim Tran, Jane A. Weintraub, Joel White, Robert Wilson, Ling Zhan

Mentored students: Lawrence Li, Gloria Khoo, Maureen Khoo, Dan Walton

Support: US DHHS/NIH/NIDCR R01 DE 12455In-kind: OMNII Pharmaceuticals, Oral B, Proctor & Gamble

Page 2: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

Background:Background:The Caries BalanceThe Caries Balance

Protective Factors• Saliva flow & components• Fluoride - remineralization• Antibacterials:chlorhexidine, xylitol, new?

No CariesCaries

Pathological Factors• Acid-producing bacteria• Frequent eating/drinking fermentable carbohydrates •Sub-normal saliva flow & function

Page 3: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

chinowaKyoto, Japan June 2001

Page 4: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

Overall Aim of the Study

The overall objective of the study was: To provide clinical evidence that caries risk assessment with aggressive preventive and therapeutic measures can restore the balance between caries pathological and protective factors, thereby reducing new caries formation over 2 years

Page 5: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

Caries Management Study

3 72

Visit 1DMFS

Radiographs

Con

trol

Inte

rven

tion

Final DMFSRadiographs

Randomization

Restorations, Antibacterial

+/-Fluoride Rinses

All Restorations

Complete

2

4-6

Conventional Tx Plan

Restorations

3 7

Final DMFSRadiographs

All Restorations

Complete

4-6

2 YearsSalivary MS, LB, F every visit

Visit:

Visit:

Salivary MS, LB, F every visit

high med low

Page 6: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

Methods – Study Enrollment

•3 yr randomized clinical trial: 231 adults (18+ yrs)•Eligibility: 16+ teeth, 1-7 cavities, no root caries

•Restorations completed (RC) in average of 12 mo•Saliva samples (paraffin stimulated) every 6 mo:

selective microbiology (MS & LB, CFU/ml saliva) fluoride (F, ppm)

Page 7: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

Methods – Tx GrpsPreventive Intervention (PI) Group (n=116)

Chlorhexidine gluconate (0.12%) rinse, 1/day for 2 weeks every 3 months (or 1 week / month) based on salivary MS and LB levels

Fluoride mouthrinse daily (0.05% NaF) based on salivary F level

Control (C) Group - conventional care (n=115)No fluoride or chlorhexidine rinse suppliedProviders unaware of salivary assay results

•2 year follow-up after RC to final examination•Final examination (1 calibrated examiner - JAW)

Page 8: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

Log10 (Mutans Strep + 1) (CFU/ml)

Overall Caries Risk

F > 0.08 ppmLow < 4.0

Medium4.0 – <6.0

High> 6.0

Low< 1.3

Low Medium High

Medium1.3 – <3.0

Medium Medium High

High> 3.0

Medium High High

Log10(LB +1) (CFU/ml)

Page 9: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

Decayed Surfaces vs. log MS and log LB

High Bacterial Challenge

Baseline Bacterial Levels vs Decay

Page 10: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

0 1 2 3 4 5 6 70

1

2

3

4

5

Log MS Control

Log MS Intervention

Visit # - 6 month intervals

(CHX +/- F)

Restorations

Log MS vs Time Mean (SE)

Page 11: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

0 1 2 3 4 5 6 70

1

2

3

4

5

Log LB ControlLog LB Intervention

Visit # - 6 month intervals

Restorations

Log LB vs Time Mean (SE)

(CHX +/- F)

Page 12: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

Final Caries Status Related to Baseline Bacterial Levels CaMRA Randomized Clinical Trial

Page 13: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

Final Caries Status Related to Baseline Bacterial Levels CaMRA Randomized Clinical Trial

Page 14: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

Final Caries Status Related to Bacterial Levels 6 Months Prior CaMRA Randomized Clinical Trial

Page 15: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

Final Caries Status Related to Bacterial Levels 6 Months Prior CaMRA Randomized Clinical Trial

Page 16: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

Mean (SE) ΔDMFS, ΔDFS

0

1

2

3

4

5 p = 0.106

p = 0.097

n=52

n=57

n=52

n=57

Page 17: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

Limitations• Lower enrollment than (231 not 296),

but better retention than planned slightly smaller sample size (109 not 122)

• Compliance

Page 18: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

Overall Conclusions• Oral MS challenge stays essentially the same

even after restoring all teeth with cavities

• Chlorhexidine gluconate (0.12%) +/- F (0.05% NaF) intervention is valuable during and after treatment to reduce caries risk status

• Caries risk status can be determined from MS, LB counts and F concentration in saliva

• Favorably altering the Caries Balance somewhat reduces subsequent caries levels

Page 19: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

Did We Prove Our Hypothesis?

This randomized clinical trial: provided clinical evidence that caries risk assessment with aggressive preventive and therapeutic measures can beneficially alter the balance between caries pathological and protective factors somewhat reducing new caries formation over 2 years

Page 20: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006

Reflections? Questions?

Page 21: Caries management by risk assessment: The CaMBRA ... · Caries management by risk assessment: The CaMBRA randomized clinical trial Principal Investigator: John D. B. Featherstone

© Stuart A. Gansky 2006